Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
0.7563
+0.0563 (8.04%)
At close: Nov 11, 2026, 4:00 PM EST
0.7453
-0.0110 (-1.45%)
After-hours: Nov 11, 2026, 6:47 PM EST
Metagenomi Therapeutics Employees
Metagenomi Therapeutics had 113 employees as of June 30, 2026. The number of employees decreased by 58 or 33.92% compared to the same quarter last year. That makes Metagenomi Therapeutics the 30,706th largest employer in the world and 3,909th in the United States.
Employees
113
Change (1Y)
-58
Growth (1Y)
-33.92%
Revenue / Employee
$62,708
Profits / Employee
-$833,584
Market Cap
28.57M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 113 | -58 | -33.92% |
| Mar 31, 2026 | 118 | -58 | -32.95% |
| Dec 31, 2025 | 119 | -83 | -41.09% |
| Sep 30, 2025 | 124 | -83 | -40.10% |
| Jun 30, 2025 | 171 | -57 | -25.00% |
| Mar 31, 2025 | 176 | -61 | -25.74% |
| Dec 31, 2024 | 202 | -34 | -14.41% |
| Sep 30, 2024 | 207 | -16 | -7.17% |
| Jun 30, 2024 | 228 | 28 | 14.00% |
| Mar 31, 2024 | 237 | 37 | 18.50% |
| Dec 31, 2023 | 236 | - | - |
| Sep 30, 2023 | 223 | - | - |
| Jun 30, 2023 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evaxion | 46 |
| BeyondSpring | 44 |
| NextCure | 40 |
| Aardvark Therapeutics | 28 |
| Filana Therapeutics | 20 |
| ABVC BioPharma | 19 |
| Edesa Biotech | 17 |
| Lite Strategy | 5 |
MGX News
- 19 hours ago - Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 1 day ago - Metagenomi announces FDA clearance of IND application for MGX-001 - TheFly
- 1 day ago - Metagenomi Therapeutics Announces FDA Clearance of Investigational New Drug Application for MGX-001 and Reports Third Quarter 2026 Financial Results - GlobeNewsWire
- 1 day ago - Metagenomi Therapeutics Earnings release: Q3 2026 - Filings
- 1 day ago - Metagenomi Therapeutics Quarterly report: Q3 2026 - Filings
- 7 days ago - Metagenomi Therapeutics to Present Preclinical Data Supporting MGX-001, a Potential One-Time Therapy for Hemophilia A, in Oral Presentation at 68th American Society of Hematology Annual Meeting - GlobeNewsWire
- 22 days ago - Metagenomi Therapeutics Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 4 weeks ago - Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare Conference - GlobeNewsWire